Research progamme: anti-polyomavirus infection monoclonal antibodies - IDBiologics
Alternative Names: BK virus prevention - IDBiologicsLatest Information Update: 31 Mar 2025
At a glance
- Originator IDBiologics
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Polyomavirus infections
Most Recent Events
- 08 Mar 2025 Preclinical trials in Polyomavirus infections (Prevention) in USA (Parenteral) prior to March 2025 (IDBiologics pipeline, March 2025)